 | |
 | |
| Clinical data | |
|---|---|
| Other names | 4-Cyclopropylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-cyclopropylthiophenethylamine; SESQUI |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | "Several hours"[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO2S |
| Molar mass | 253.36 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 203.5 to 204.5 °C (398.3 to 400.1 °F) |
| |
| |
 N Y (what is this?) (verify) | |
2C-T-15, also known as4-cyclopropylthio-2,5-dimethoxyphenethylamine, is apsychedelicphenethylamine of the2C family.[1] It was presumably first synthesized byAlexander Shulgin and reported in his bookPiHKAL (Phenethylamines i Have Known And Loved).[1]
The dose range of 2C-T-15 is typically 30mg or more. Its duration is unspecified byShulgin, and itsentry in PiHKAL says it lasts for "several hours."[1] The effects are not prominent, and 2C-T-15 is not very potent.
The toxicity of 2C-T-15 is not well documented. 2C-T-15 is much less potent than 2C-T-7, but it may be expected that at very high doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.[citation needed]
The mechanism that produces 2C-T-15's hallucinogenic and entheogenic effects has not been specifically established; however, it is most likely to result from action as a5-HT2Aserotonin receptoragonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.[citation needed]
2C-T-15 is the2 carbonhomologue ofAleph-15, which has not been synthesized.[1] The full chemical name is 2-[4-(2-cyclopropylthio)-2,5-dimethoxyphenyl]ethanamine.[1] The drug hasstructural properties similar to2C-T-2 and other drugs in the2C-T series.[1]
2C-T-15 was first described in thescientific literature byAlexander Shulgin and colleagues in 1991.[2]
As of October 31, 2016, 2C-T-15 is a controlled substance (Schedule III) in Canada.[3]
2C-T-15 is a class A drug in the UK under theMisuse of Drugs act.
2C-T-15 is not explicitly illegal in the USA, but possession and sales of 2C-T-15 could be prosecuted under theFederal Analog Act because of its structural similarities to2C-T-7.
